Free Trial

CVS Health (CVS) Competitors

CVS Health logo
$66.54 -1.03 (-1.52%)
Closing price 03:58 PM Eastern
Extended Trading
$65.73 -0.81 (-1.22%)
As of 04:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CVS vs. WBA, GRDN, PETS, YI, CJJD, NVO, MRK, AZN, NVS, and ABT

Should you be buying CVS Health stock or one of its competitors? The main competitors of CVS Health include Walgreens Boots Alliance (WBA), Guardian Pharmacy Services (GRDN), PetMed Express (PETS), 111 (YI), China Jo-Jo Drugstores (CJJD), Novo Nordisk A/S (NVO), Merck & Co., Inc. (MRK), AstraZeneca (AZN), Novartis (NVS), and Abbott Laboratories (ABT).

CVS Health vs.

CVS Health (NYSE:CVS) and Walgreens Boots Alliance (NASDAQ:WBA) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, community ranking, analyst recommendations, earnings, risk, profitability and media sentiment.

CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 3.9%. Walgreens Boots Alliance pays an annual dividend of $1.00 per share and has a dividend yield of 9.0%. CVS Health pays out 72.7% of its earnings in the form of a dividend. Walgreens Boots Alliance pays out -9.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Walgreens Boots Alliance is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, CVS Health had 27 more articles in the media than Walgreens Boots Alliance. MarketBeat recorded 63 mentions for CVS Health and 36 mentions for Walgreens Boots Alliance. CVS Health's average media sentiment score of 1.15 beat Walgreens Boots Alliance's score of 0.26 indicating that CVS Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CVS Health
46 Very Positive mention(s)
5 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Walgreens Boots Alliance
9 Very Positive mention(s)
4 Positive mention(s)
20 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Neutral

CVS Health received 269 more outperform votes than Walgreens Boots Alliance when rated by MarketBeat users. Likewise, 75.53% of users gave CVS Health an outperform vote while only 65.15% of users gave Walgreens Boots Alliance an outperform vote.

CompanyUnderperformOutperform
CVS HealthOutperform Votes
1432
75.53%
Underperform Votes
464
24.47%
Walgreens Boots AllianceOutperform Votes
1163
65.15%
Underperform Votes
622
34.85%

CVS Health has a beta of 0.54, indicating that its stock price is 46% less volatile than the S&P 500. Comparatively, Walgreens Boots Alliance has a beta of 0.62, indicating that its stock price is 38% less volatile than the S&P 500.

CVS Health presently has a consensus price target of $70.41, indicating a potential upside of 4.25%. Walgreens Boots Alliance has a consensus price target of $10.59, indicating a potential downside of 5.01%. Given CVS Health's stronger consensus rating and higher probable upside, equities analysts clearly believe CVS Health is more favorable than Walgreens Boots Alliance.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVS Health
0 Sell rating(s)
3 Hold rating(s)
17 Buy rating(s)
1 Strong Buy rating(s)
2.90
Walgreens Boots Alliance
4 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.85

80.7% of CVS Health shares are held by institutional investors. Comparatively, 58.6% of Walgreens Boots Alliance shares are held by institutional investors. 0.2% of CVS Health shares are held by insiders. Comparatively, 17.5% of Walgreens Boots Alliance shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

CVS Health has higher revenue and earnings than Walgreens Boots Alliance. Walgreens Boots Alliance is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVS Health$372.81B0.23$4.61B$3.6618.45
Walgreens Boots Alliance$150.41B0.06-$8.64B-$10.24-1.09

CVS Health has a net margin of 1.24% compared to Walgreens Boots Alliance's net margin of -5.87%. Walgreens Boots Alliance's return on equity of 17.61% beat CVS Health's return on equity.

Company Net Margins Return on Equity Return on Assets
CVS Health1.24% 9.11% 2.71%
Walgreens Boots Alliance -5.87%17.61%2.89%

Summary

CVS Health beats Walgreens Boots Alliance on 15 of the 21 factors compared between the two stocks.

Remove Ads
Get CVS Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CVS vs. The Competition

MetricCVS HealthDrug stores & proprietary stores IndustryMedical SectorNYSE Exchange
Market Cap$85.15B$10.70B$5.74B$19.74B
Dividend Yield3.92%6.44%4.55%3.75%
P/E Ratio18.4587.5724.7434.14
Price / Sales0.230.31393.1128.93
Price / Cash7.1667.5038.1617.54
Price / Book1.120.837.164.65
Net Income$4.61B-$585.83M$3.20B$1.02B
7 Day Performance0.08%1.41%2.86%1.47%
1 Month Performance6.12%4.54%7.01%-0.75%
1 Year Performance-14.50%-14.55%15.61%7.33%

CVS Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CVS
CVS Health
4.9613 of 5 stars
$66.54
-1.5%
$70.41
+5.8%
-13.9%$83.89B$372.81B18.18300,000Dividend Announcement
Positive News
WBA
Walgreens Boots Alliance
3.4701 of 5 stars
$11.13
+0.3%
$10.59
-4.8%
-45.8%$9.62B$150.41B-1.09325,000Upcoming Earnings
GRDN
Guardian Pharmacy Services
N/A$21.46
+0.5%
$22.00
+2.5%
N/A$1.36B$1.17B0.003,200Upcoming Earnings
Lockup Expiration
PETS
PetMed Express
0.2139 of 5 stars
$4.16
-2.1%
$3.50
-15.9%
-10.9%$85.93M$247.01M416.42210
YI
111
1.1353 of 5 stars
$10.00
-4.7%
N/A-3.7%$85.52M$14.40B-2.501,520Earnings Report
Analyst Forecast
News Coverage
Gap Up
CJJD
China Jo-Jo Drugstores
N/AN/AN/AN/A$10.05M$147.13M0.00980Analyst Forecast
Gap Down
NVO
Novo Nordisk A/S
4.6937 of 5 stars
$75.52
-1.7%
$145.25
+92.3%
-41.5%$338.90B$290.40B22.9554,400
MRK
Merck & Co., Inc.
5 of 5 stars
$92.07
-1.1%
$117.12
+27.2%
-25.4%$232.57B$64.17B13.6869,000
AZN
AstraZeneca
2.2758 of 5 stars
$74.30
-0.8%
$89.75
+20.8%
+11.8%$230.42B$54.07B32.8883,500Positive News
NVS
Novartis
2.2673 of 5 stars
$111.49
-0.6%
$123.38
+10.7%
+15.5%$227.89B$51.72B18.9675,883
ABT
Abbott Laboratories
4.7718 of 5 stars
$127.61
+1.0%
$137.94
+8.1%
+15.1%$221.32B$41.95B16.68115,000Positive News
Remove Ads

Related Companies and Tools


This page (NYSE:CVS) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners